baber/WOPTO huggingface dataset:
Patent PT-972761-E (PT)
Inventor: KIM SEONG-SOO
IPC: C07C381/12
Filed: 1999-07-13
Abstract: This invention relates to a sulfonium salt, including its manufacturing method, which is effectively used as a photoacid initiator or radical photoinitiator during polymerization and a photoacid generator, leaving the protection groups of organic compounds, especially as an useful photoacid generator of the chemically amplified photoresist employed in semiductor materials. Since the sulfonium salt of this invention, so prepared via one-step reaction between sulfoxide compound and aromatic compound in the presence of perfluoroalkanesulfonic anhydride, has the advantages in that by overcoming some shortcomings of the prior art to prepare the sulfonium salt via two steps using Grinard reagent, this invention may provide a novel sulfonium salt with higher yield which cannot be achieved in the prior art and also to prepare even any conventional sulfonium salt having better yield.
Patent PT-1016678-E (PT)
Inventor: PERES RICHARD
IPC: C08F259/04
Filed: 1999-12-22
Abstract: Production of a latex containing vinyl chloride polymer particles comprises polymerizing the corresponding monomer(s) in an aqueous microsuspension containing: (a) a water-soluble metal salt; (b) an alkali metal or ammonium salt of a fatty acid containing 8-22 carbon (C) atoms; (c) an alkali metal sulfoxylate, sulfite or metabisulfite reducing agent; (d) seed polymer particles containing an organo soluble initiator; and optionally (e) a seed polymer.  Independent claims are also included for the following:  (1) production of vinyl chloride polymers by drying the latex;  (2) production of plastisols by mixing the polymers of with a plasticizer;  (3) vinyl chloride polymers obtainable by process (1);  (4) plastisols obtainable by method (2).
Patent PT-1076522-E (PT)
Inventor: CRONIN NIGEL
IPC: A61B18/00
Filed: 1999-05-05
Abstract: A microwave applicator for applying electromagnetic radiation at microwave frequency includes a coaxial input for a microwave signal input and a waveguide for receiving and propagating the microwave signal input. Dielectric material is positioned within the waveguide and extends beyond the waveguide to form an antenna for radiating microwave energy. The coaxial input has direct in-line transition to the dielectric-filled waveguide. Preferably, this direct in-line transition is achieved by the central conductor of the coaxial input extending axially centrally into the waveguide so as to excite microwaves in the waveguide. A lateral conductor extends radially from the central conductor to assist the launch of the microwaves into the waveguide. Preferably, the applicator includes a temperature sensor which is directly connected to the coaxial input.
Patent IE-900012-L (IE)
Title: Multi-dose syringe
IPC: A61M5/31
Filed: 1990-01-03
Abstract: A prefilled syringe comprising a phial (11) containing a measured quantity of an injectable product, a plunger (5) to expel the product out of the phial through a needle, and a two-part housing (1,2) for the phial and plunger in which the two parts are connected by interengaging screw threads (3,4). A stop surface on one housing part cooperates with a corresponding surface (7) on the plunger to limit displacement of the plunger (5) into the phial (11), and the position relative to the phial of the stop surface can be varied by rotating the two housing parts (1,2) relative to one another. A graduated dosing ring (19) is mounted coaxial with, adjacent to, and rotatable relative to both housing parts (1,2).
Patent IE-780108-L (IE)
Title: Cable production
IPC: H01B13/24
Filed: 1978-01-18
Abstract: In the method for producing an electric cable having stress relief, high-tensile stress-relieving members (28, 23) inside the injection head (10) of an extrusion machine are inserted into the still viscous cable sheath (14) in such a way that each stress-relieving member (23) is entirely surrounded by sheath material and is provided with a corrugation after leaving the extruder. The method permits the corrugation of the stress-relieving members (23) to be produced independently of the type of sheath material. The corrugation of the stress-relieving members (23) is brought about by selecting the speed of the sheath material in the injection head (10) of the extruder and the speed of the stress-relieving members embedded in said material to be higher than the speed of the cable core (13). As a result, after leaving the extruder the cable sheath (14) experiences strand widening which causes the corrugation of the stress-relieving members (23). <IMAGE>
[GB1565763A]
Patent IE-880141-L (IE)
Title: Microbicidal composition
IPC: A01N43/653
Filed: 1988-01-20
Abstract: 1. Claims for the Contracting States : DE, GB, FR, IT, NL, SE, LI, CH, BE, AT, LU, GR 1-phenoxyphenyl-1-triazolylmethyl-carbinols of formula I see diagramm : EP0275955,P12,F4 in which R1 is fluorine, chlorine or bromine, R2 is fluorine, chlorine, bromine or methyl, and the acid addition salts with phytophysiologically tolerable organic and inorganic acids. 1. Claims for the Contracting State : ES A process for the preparation of the 1-phenoxyphenyl-1-triazolylmethyl-carbinols of formula I see diagramm : EP0275955,P13,F5 in which R1 is fluorine, chlorine or bromine and R2 is fluorine, chlorine or bromine or methyl and acid addition salts thereof, characterised in that 1H-1,2,4-triazole or a metal salt thereof is condensed with a 4-phenoxy-acetophenone of formula II see diagramm : EP0275955,P14,F1 in which R1 and R2 have the meanings given above and X is a nucleofugal leaving group, and the resulting 2-(diphenyl ether)-1-(1H-1,2,4-triazol)-ethan-2-one of formula IV see diagramm : EP0275955,P14,F2 in which R1 and R2 have the meanings given above is reduced with hydrogen or a hydrogen donor.
Patent IE-870344-L (IE)
Title: 7-oxabicyclo £2,2,1| heptane derivatives
IPC: A61P43/00
Filed: 1987-02-11
Abstract: Hydroxamic acids of 7-oxabicyclo (2.2.I) heptane substd. (or thioether) prostaglandin analogues of formula (I) including all stereoisomers are new. A = O or S(=O)q; q = 0-2; m = 1 or 2; n = 1-8; p = 1-5; X = O or S(=0)q'; q' = 0-2 when A = O or q' = O when A = S; R1 = H, lower alkyl, aryl, aralkyl, cycloalkyl, alkanoyl or aroyl; R2 = lower alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl or 2-12C alkenyl; ''lower'' alkyl (alone or as part of another gp) contains 1-12C and is opt. substd. with halo, CF3, alkoxy, aryl, alkaryl, haloaryl, cycloalkyl or alkylcycloalkyl; aryl (alone or as part of another gp) contains 6-10C in the ring position and is opt. mono- or di-substd. by alkyl, halo and/or alkoxy; cycloalkyl (alone or as part of another gp) contains 3-12C and is opt. mono- or di-substd. by halo, lower alkyl and/or lower alkoxy; (CH2)m, (CH2)n and (CH2)p may independently contain 1 or 2 lower alkyl and/or halo substits.
Hydroxamic acids of 7-oxabicycloheptane substituted ether prostaglandin analogs are provided having the structural formula <CHEM> wherein Q is -CH2-A-(CH2)m- or (CH2)t; X is @@@@ O, Y is O or @@@@ and including all stereoisomers thereof. <??>The compounds are inhibitors of DELTA <5>-lipoxygenase and inhibitors of prostaglandin and leukotriene biosynthesis and as such are useful, for example, as anti-allergy and anti-inflammatory agents and also as antipsoriatic agents. 
[EP0232912A1]
Patent IE-40672-L (IE)
Title: Testing underwater pipeline
IPC: G01M/
Filed: 1974-02-21
Abstract: A pipeline closing head, for use in testing a pipeline after it has been laid on a submerged bed by subjecting the pipeline temporarily to internal pressure through the use of filling and emptying balls, is constituted by a hollow cylindrical body having a crowned closing element at one end and containing, at its other end, an air tight chamber housing the filling and emptying balls. Ducts and control valves through which fluid is supplied to said chamber to activate the filling and emptying balls and supply fluid pressure to the interior of the pipeline are housed within the cylindrical body so that they do not overhang the closing head, which may slide along a conventional ramp for the pipeline.
[US3948085A]
Patent IE-880461-L (IE)
Title: Gelatin coated caplets and process for making same
IPC: A61J3/10
Filed: 1988-02-19
Abstract: A capsule-like medicament, method for producing such medicaments and apparatus are disclosed. The method provides a procedure for coating solid cores, such as caplets (16), with gelatinous coatings to produce a shiny, capsule-like medicament. Such medicaments are achieved by individually dipping and drying first one end (110), and then the other end (104), of each caplet (16) to provide a coating which is smoother and easier to swallow than an uncoated caplet (16). The production of these capsule-like medicaments is readily facilitated by simple and inexpensive modifications which can be made to existing empty gelatin capsule making equipment.
[EP0279682A2]
Patent IE-39339-L (IE)
Title: Thread storage feeder
IPC: B65H51/22
Filed: 1974-03-11
Abstract: 1404447 Weft measuring drums IRO VISTAHOLM AB 12 March 1974 [13 March 1973] 11038/74 Heading D1E A weft measurer comprises a hollow shaft 4, through which the weft passes, which rotates the measuring drum 1 and a flyer 6 the drum having at one end, a swash plate 10 which moves the windings along the drum and, at the other end, a tapered flange 11 which is movable towards the swash plate 10 to open out the windings and to allow them to be pulled axially off the drum over the flyer ring 5 and through an eyelet 18. The flange 11 moves in axial grooves in the drum surface and is utilised to operate a switch 15 switching on and off an electromagnetic clutch connecting the driving motor 7 to the drum 1.
[GB1404447A]
Patent IE-810638-L (IE)
Title: 6-chlorobenzoxazolone
IPC: C07D263/58
Filed: 1981-03-23
Abstract: Process for the preparation of optionally hydroxymethylated 6-chlorobenzoxazolone, which consists in chlorinating and, if appropriate, hydroxymethylating benzoxazolone in a mixture of water and dioxane.
Patent IE-35323-L (IE)
Title: Tropan-3-ol derivatives
IPC: C07D451/06
Filed: 1971-06-01
Abstract: 1351526 α-Phenyl-cyclopentane acetic acidnortropine esters BOEHRINGER INGELHEIM GmbH 28 May 1971 [1 June 1970] 17926/71 Heading C2C Novel ester of the Formula I wherein R 1 is hydrogen or halogen or C 1-4 alkyl or alkoxy, R 2 is hydrogen, C 1-5 alkyl, C 3-6 cycloalkyl with the proviso that where R 1 is hydrogen and R 2 is methyl the α-phenyl-cyclopentane acetoxy moiety is # to the tropine moiety and acid addition and quaternary ammonium salts thereof may be prepared either by reacting a compound II where R 2 is other than hydrogen with an organic acid derivative III wherein Y is halogen, C 1-4 alkoxy or another group removable as an anion and if desired dealkylating the N-alkyl compound produced to give R 2 = H or by N-alkylating a compound I in which R 2 is hydrogen. Pharmaceutical compositions of I show anticholinergic activity when administered orally, parenterally or rectally with the usual excipients.
[GB1351526A]
Patent IE-890898-L (IE)
Title: THE USE OF pSG5 AS A TEMPERATURE-SENSITIVE PLASMID
IPC: C12N1/20
Filed: 1989-03-22
Abstract: The streptomycetes plasmid pSG5 is temperature-sensitive. It is thus possible with the aid of the pSG5 replicon to prepare temperature-sensitive hybrid plasmids. The latter are suitable for screening for DNA segments which are homologous with DNA segments of the hybrid plasmid.
Patent FI-843809-L (FI)
Inventor: SCHULTZ ELMER G
IPC: B65H37/04
Filed: 1984-09-27
Abstract: The aligner sealer (10) includes a base or frame (14), heating structure (16), infeed conveyor structure (18), output conveyor structure (20) and stacking rack (22). Form sheets are fed in groups on the infeed conveyor (18) through the heating stucture (16), where they are sealed into form sets, then fed onto the outfeed conveyor (20) and stached against the rack (22). The infeed conveyor structure (18) includes means for aligning the from sheets of the groups before the groups enter the heating means (16).
Patent FI-851021-L (FI)
Inventor: LEHMANN PETER
IPC: G03G5/04
Filed: 1985-03-14
Abstract: The disclosed light-sensitive recording material is composed of an electrically conductive support, suitable for the production of printing forms or printed circuits, an a photoconductive layer system containing a photoconductor, a binder, a sensitizing dye and conventional additives. The photoconductive system comprises (A) a single photoconductive layer, or multiple layers, applied to the support and (B) a light-sensitive covering layer which contains at least one photochemically reactive compound. The use of the recording material in a process for the production of printing forms and printed circuits is also disclosed.
Patent IE-851106-L (IE)
Title: Storing foodstuffs
IPC: B65D25/06
Filed: 1985-05-02
Abstract: A food storage and preparation device including a container assembly and a grid assembly. The grid assembly includes a tray and handle arrangement which is pivotable between a first position wherein the tray is adjacent the base of the container and a second position wherein the tray is positioned above the base forming a dual level arrangement with space for foodstuffs below and above the tray. The device further includes a detent arrangement for maintaining the handles in the first and second positions.
[US4609237A]
Patent IE-821118-L (IE)
Title: Heparinoid
IPC: C08B37/10
Filed: 1982-05-10
Abstract: A new anti-thromboticum based on a mixture of oligo- and polysaccharides is provided. The invention also relates to methods for preparation thereof and to pharmaceutical compositions including the said anti-thromboticum. The new product is of natural origin and can be obtained from mammal tissue, particularly intestinal mucous. The product is useful because of its high "benefit/risk" ratio (i.e. the ratio between the anti-thrombotic activity and the haemorrhagic activity).
Patent IE-32479-L (IE)
Title: 3-indolinyl-2-amino-propionitriles
IPC: C07D209/38
Filed: 1968-11-01
Abstract: 1,251,985. lndolinonyl-aminopropionitriles and their production. AGRIPAT S.A. 1 Nov., 1968 [3 Nov., 1967], No. 51787/68. Heading C2C. 3 - (3 - Hydroxy - indolin - 2<SP>1 </SP> - on - 3<SP>1 </SP> - yl) - 2- aminopropionitriles of the formula wherein R<SP>1</SP> represents an unsubstituted or substituted aliphatic or araliphatic hydrocarbon radical which may also be substituted by a heterocyclic radical, R<SP>2</SP> represents an unsubstituted or substituted aliphatic or araliphatic hydrocarbon radical which may also be substituted by a heterocyclic radical or a monocarbocyclic aryl radical, or R 1 and R 2 together with the adjacent nitrogen atom represent a 5- to 7-membered heterocyclic radical which may contain further hetero atoms as ring members, R 3 represents hydrogen, an unsubstituted or substituted aliphatic or araliphatic hydrocarbon radical having 1 to 8 carbon atoms, a piperidinoalkyl radical or an acyl radical and R 4 to R 7 independently of each other each represent hydrogen, a lower (up to C 8 ) alkyl, haloalkyl, hydroxyalkyl, dialkylaminoalkyl, alkoxy, alkoxyalkoxy, alkylamino, dialkylamino, acylamino, mono- or di-alkyl-carbamoyl, alkoxycarbonyl or acyloxy radicals, a halogen atom, or the hydroxyl, cyano, carbamoyl, carbonyl or nitro group, may be obtained by reacting an isatin of the formula with lactonitrile and with a secondary amine of the formula R 1 R 2 NH. The reaction is suitably carried out employing approximately equimolar amounts of the reactants at a temperature between 0‹ and 50‹ C., optionally in the presence of an inert diluent or solvent. Many examples of the products are given.
[GB1251985A]
Patent IE-831383-L (IE)
Title: High glucose-determining analytical element
IPC: G01N33/52
Filed: 1983-06-13
Abstract: An analytical element for quantitatively determining high levels of glucose in blood is made by (a) impregnating a carrier with a first solution, having dissolved therein 4-aminoantipyrine and 3-hydroxy-2,4,6-triiodobenzoic acid or 3,5-dichloro-2-hydroxy-benzene sulfonic acid or salts thereof, a glucose oxidase and a peroxidase, and drying the carrier; and (b) applying to the carrier a second solution of a film-forming agent in a volatile solvent, and drying to remove the volatile solvent and leave a film over the dried first impregnant.
[US4427770A]
Patent IE-38090-L (IE)
Title: Hydrogen fluoride
IPC: C01B7/19
Filed: 1973-08-15
Abstract: 1400862 Ammonia: hydrogen fluoride: calcium fluoride FITZWILTON Ltd 17 Aug 1973 [24 Aug 1972 29 Jan 1973 24 April 1973 21 May 1973] 39400/72 4373/73 19378/73 and 24149/73 Heading C1A Ammonium fluoride is hydrolysed to ammonia and hydrogen fluoride by heating in solution with an excess of a soluble metal fluoride capable of forming a bifluoride, whereby ammonia is released and the metal fluoride reacts with the HF to form the corresponding bifluoride, which is recovered from the solution substantially free from ammonia, and the recovered bifluoride is decomposed by heating to form HF. The soluble metal fluoride may be an alkali metal fluoride, particularly potassium fluoride, and the weight ratio of fluoride ions to ammonium ions is greater than 2À5 to 1. The excess of KF used may be such that the crystallized solids comprise a mixture of KF and KHF 2 , the bifluoride content being in the range from 95 to 35%. Water should be removed continuously from the system, thus carrying out the reaction at the boiling point. The solid product may be decomposed at a temperature within the range 250 to 600 C. If desired the KHF 2 may be converted into NaHF 2 which decomposes into NaF and HF at lower temperatures than the KHF 2 . The ammonia produced may be introduced into the off gases containing hydrofluosilicic acid from a phosphonic acid plant, silica separating out and ammonium fluoride being formed. The liquid phase from the hydrolysis step may if desired be reacted with calcium carbonate to produce calcium fluoride which in its turn may be used as a source of hydrofluoric acid.
[GB1400862A]
Patent IE-811891-L (IE)
Title: Treating insufficiencies in hematosis
IPC: A61K31/53
Filed: 1981-08-18
Abstract: A method of treating insufficiencies in hematosis, such as hypoxemia, cardiac insufficiency, and polyglobulia, involving treatment of a patient suffering from such insufficiency with the compound almitrine or a pharmaceutically-acceptable salt thereof in extremely low daily dosages, between 0.5 and 3 mg/kg orally or 0.05 to 0.3 mg/kg intravenously, an oral unit dosage form of the said active ingredient, containing between 20 and 70 mg of active ingredient together with a pharmaceutically-acceptable carrier or diluent, preferably about 50 mg of the active ingredient.
[US4364946A]
Patent IE-902105-L (IE)
Title: A method of and an apparatus for degassing and maintaining a¹low hydrogen content in liquid aluminium alloys while they¹are being carried in ladles
IPC: B65D88/74
Filed: 1990-06-12
Abstract: Process and apparatus for degassing and maintaining a low hydrogen content in liquid aluminium alloys during their transport in ladles. The process is characterised in that a stream of gases which are inert towards aluminium is circulated in the ladle at a low and controlled flow rate and the said gas(es) is (are) then removed from the ladle. The apparatus consists of at least one ladle (1) and at least one bottle (4) containing a gas under pressure, these being joined together by a circuit (5) comprising a pressure reducer (6), a flow- meter (7) and a gas injection system, the said ladle being equipped in its upper part with a controlled gas leakage system. This invention makes it possible to reduce and avoid the gassing of metal during its transport and to provide the users with an aluminium alloy which is suitable for moulding articles which are metallurgically healthy. <IMAGE>
Patent IE-902164-L (IE)
Title: Treatment of postmenopausal disorders
IPC: A61P5/00
Filed: 1990-06-15
Abstract: The present invention relates to a pharmaceutical kit in dosage unit form for use in the treatment of postmenopausal disorders comprising separate dosage units for uninterrupted sequential daily, oral administration, said kit comprised of:   (a) 69 separate daily dosage units for sequential daily oral ingestion of a naturally occurring or synthetic estrogenic compound effective in the prevention of postmenopausal disorders; (b) 14 separate daily dosage units for sequential daily, oral ingestion of a naturally occurring or synthetic estrogenic compound and a progesterone compound having a progestational activity effective in preventing the development of endometrial hyperplasia; and (c) if desired, 6-8 separate daily dosage units for sequential daily, oral ingestion of a compound free of estrogen and progestogen. g
Patent IE-792250-L (IE)
Title: Electrochemical cell
IPC: H01M10/04
Filed: 1979-11-23
Abstract: Apparatus for inserting a core member for an electrochemical cell into an open-ended cell casing, including: casing support means; a collet assembly comprised of annular segments movable relative to each other so as to fix the dimension of the perimeter of an interior guiding surface, the guiding surface preferably being radially inwardly tapered; and means for advancing the core member through the collet assembly and into the casing. The apparatus also comprises means for controlling the position of the annular segments of the collet assembly selectively to increase or decrease the perimeter of the guiding surface.
[US4296546A]
Patent IE-862793-L (IE)
Title: Plasmid expression in yeast
IPC: C12N15/67
Filed: 1986-10-23
Abstract: A method of expressing genes in yeast by introducing into a yeast cell a recombinant DNA segment containing both the gene to be expressed and a 5 min  flanking region comprising a promoter sequence, and culturing of the transformed yeast cells in a growth medium, using as the recombinant DNA segment a segment, of which the 5 min  flanking region comprises a first DNA fragment containing a promoter sequence in combination with a second DNA fragment containing a leader sequence regulated on the posttranscriptional level by heme, heme analogs, or heme precursors. Furthermore DNA-fragments and plasmids to be used when carrying out the method. When carrying out the method according to the invention an increased expression of genes is obtained by a reduced genetic load of the host cell and a more optimal utilization of the protein synthesis apparatus and the energy metabolism.
Patent IE-832804-L (IE)
Title: Applying a lining to a conduit such as a chimney flue
IPC: B05C7/02
Filed: 1983-11-29
Abstract: Apparatus for applying a lining material to a conduit comprises an elongate flexible pipe for lining material. A dispensing nozzle is provided at one end of the pipe and the other end of the pipe is squeezed between a pair of driven rollers to expel the lining material through the dispensing nozzle as the pipe is drawn through the conduit. A pair of circular steel wire brushes are mounted on the pipe below the dispensing nozzle center the pipe in the conduit and also clean the side wall of the conduit ahead of the nozzle. The cross-sectional area of the pipe is calculated so that as the pipe is pulled back down the conduit it deposits an evenly distributed, predetermined amount of lining material on the side wall of the conduit.
[US4735168A]
Patent IE-863118-L (IE)
Title: Low acetyl gellan gum blends
IPC: A23L29/269
Filed: 1986-11-26
Abstract: Blends of low-acetyl gellan gum with xanthan gum and locust bean gum are described. The combination of xanthan gum/locust bean gum modifies the brittleness of the gellan gum gel and provides a useful range and diversity of gel textures which find particular utility in gelled food formulations. In place of locust bean gum, konjak, tara, or Cassia gums may be used.
[US4647470A]